Chitosan nanoparticle delivery systems: An effective approach to enhancing efficacy and safety of anticancer drugs

Currently, cancer is the leading cause of death globally. In the absence of specific treatment and early diagnosis, procedures like surgery, chemotherapy, and radiation therapy are often used to manage the disease. However, these approaches often fail to control cancer due to inefficacy, nonspecific...

Full description

Saved in:
Bibliographic Details
Main Authors: Anil Kumar Grewal, Raj Kumar Salar
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2024-12-01
Series:Nano TransMed
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2790676024000116
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850113630148755456
author Anil Kumar Grewal
Raj Kumar Salar
author_facet Anil Kumar Grewal
Raj Kumar Salar
author_sort Anil Kumar Grewal
collection DOAJ
description Currently, cancer is the leading cause of death globally. In the absence of specific treatment and early diagnosis, procedures like surgery, chemotherapy, and radiation therapy are often used to manage the disease. However, these approaches often fail to control cancer due to inefficacy, nonspecific distribution, and side effects of the drugs. Anticancer drugs are essential in reducing cancer cell growth and helping damage those cells. Anticancer drugs often cause severe side effects and have limited bioavailability due to their nonspecific distribution throughout the body. Therefore, the development of intelligent drug release systems is essential. Nanoparticle delivery systems are promising strategies to improve therapeutic efficacy and safety, overcoming challenges. Among these systems, a natural polysaccharide called chitosan, a derivative of chitin, has gained considerable attention as a biocompatible, biodegradable, and mucoadhesive material for creating nanoparticles. Chitosan nanoparticles provide several advantages, including improved stability, cellular uptake, solubility of anticancer drugs, modulation of release kinetics, and biodistribution. Additionally, chitosan nanoparticles can be modified on their surface with ligands or stimuli-responsive moieties to achieve targeted delivery to specific cancer cells or tissues. This review explores recent advances in chitosan-based nanoparticle drug delivery, efficacy, and their applications in cancer therapy.
format Article
id doaj-art-2c1f2d7bbb88499a9cbb8eae73ec588a
institution OA Journals
issn 2790-6760
language English
publishDate 2024-12-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Nano TransMed
spelling doaj-art-2c1f2d7bbb88499a9cbb8eae73ec588a2025-08-20T02:37:06ZengKeAi Communications Co., Ltd.Nano TransMed2790-67602024-12-01310004010.1016/j.ntm.2024.100040Chitosan nanoparticle delivery systems: An effective approach to enhancing efficacy and safety of anticancer drugsAnil Kumar Grewal0Raj Kumar Salar1Department of Biotechnology Chaudhary Devi Lal University, Sirsa, 125055, IndiaCorresponding author.; Department of Biotechnology Chaudhary Devi Lal University, Sirsa, 125055, IndiaCurrently, cancer is the leading cause of death globally. In the absence of specific treatment and early diagnosis, procedures like surgery, chemotherapy, and radiation therapy are often used to manage the disease. However, these approaches often fail to control cancer due to inefficacy, nonspecific distribution, and side effects of the drugs. Anticancer drugs are essential in reducing cancer cell growth and helping damage those cells. Anticancer drugs often cause severe side effects and have limited bioavailability due to their nonspecific distribution throughout the body. Therefore, the development of intelligent drug release systems is essential. Nanoparticle delivery systems are promising strategies to improve therapeutic efficacy and safety, overcoming challenges. Among these systems, a natural polysaccharide called chitosan, a derivative of chitin, has gained considerable attention as a biocompatible, biodegradable, and mucoadhesive material for creating nanoparticles. Chitosan nanoparticles provide several advantages, including improved stability, cellular uptake, solubility of anticancer drugs, modulation of release kinetics, and biodistribution. Additionally, chitosan nanoparticles can be modified on their surface with ligands or stimuli-responsive moieties to achieve targeted delivery to specific cancer cells or tissues. This review explores recent advances in chitosan-based nanoparticle drug delivery, efficacy, and their applications in cancer therapy.http://www.sciencedirect.com/science/article/pii/S2790676024000116Anticancer drugsChitosan nanoparticlesTargeted therapyCellular uptake
spellingShingle Anil Kumar Grewal
Raj Kumar Salar
Chitosan nanoparticle delivery systems: An effective approach to enhancing efficacy and safety of anticancer drugs
Nano TransMed
Anticancer drugs
Chitosan nanoparticles
Targeted therapy
Cellular uptake
title Chitosan nanoparticle delivery systems: An effective approach to enhancing efficacy and safety of anticancer drugs
title_full Chitosan nanoparticle delivery systems: An effective approach to enhancing efficacy and safety of anticancer drugs
title_fullStr Chitosan nanoparticle delivery systems: An effective approach to enhancing efficacy and safety of anticancer drugs
title_full_unstemmed Chitosan nanoparticle delivery systems: An effective approach to enhancing efficacy and safety of anticancer drugs
title_short Chitosan nanoparticle delivery systems: An effective approach to enhancing efficacy and safety of anticancer drugs
title_sort chitosan nanoparticle delivery systems an effective approach to enhancing efficacy and safety of anticancer drugs
topic Anticancer drugs
Chitosan nanoparticles
Targeted therapy
Cellular uptake
url http://www.sciencedirect.com/science/article/pii/S2790676024000116
work_keys_str_mv AT anilkumargrewal chitosannanoparticledeliverysystemsaneffectiveapproachtoenhancingefficacyandsafetyofanticancerdrugs
AT rajkumarsalar chitosannanoparticledeliverysystemsaneffectiveapproachtoenhancingefficacyandsafetyofanticancerdrugs